Skip to main content

Table 3 Antimicrobial susceptibility pattern according to methicillin resistance

From: Epidemiology and antimicrobial susceptibility of Staphylococcus aureus in children in a tertiary care pediatric hospital in Milan, Italy, 2017—2021

 

Cotrimoxazole

Clindamycin

Macrolides

Linezolid

Daptomycin

Levofloxacin

Fusidic Acid

Mupirocin

Gentamicin

Tetracyclin

Vancomycin

MRSA

S

56 (74)

53 (70)

46 (60)

75 (99)

72 (95)

40 (53)

47 (62)

68 (89)

50 (66)

57 (75)

76 (100)

R

17 (22)

18 (24)

28 (37)

0 (0)

1 (1)

35 (46)

26 (34)

6 (8)

25 (33)

15 (20)

0 (0)

I

2 (3)

4 (5)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

4 (5)

0 (0)

NT

1 (1)

1 (1)

2 (3)

1 (1)

3 (4)

1 (1)

3 (4)

2 (3)

1 (1)

0 (0)

0 (0)

MSSA

S

166 (93)

149 (83)

144 (80)

175 (98)

175 (98)

163 (91)

162 (90)

165 (92)

164 (92)

166 (93)

176 (100)

R

11 (6)

25 (14)

31 (17)

0 (0)

0 (0)

11 (6)

11 (6)

8 (4)

10 (6)

8 (4)

0 (0)

I

0 (0)

3 (2)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

NT

2 (1)

2 (1)

4 (2)

4 (2)

4 (2)

5 (3)

6 (3)

6 (3)

5 (3)

5 (3)

0 (0)

P-value

 < 0.01

0.03

 < 0.01

1

0.3

 < 0.01

 < 0.01

0.4

 < 0.01

 < 0.01

1

  1. Data are presented as numbers (percentages)
  2. MRSA Methicillin-resistant Staphylococcus aureus, MSSA Methicillin-susceptible Staphylococcus aureus, S Sensible, R Resistant, I Intermediate, NT Not tested